Why the study?
Does permanent inhibition of guanylyl cyclase A receptor (GC-A) affect cardiac function and hypertrophy in mice?
Population
Atrial natriuretic peptide receptor (GC-A) deficient mice (GC-A-/-) and corresponding wild type mice (GC-A+/+)
Comparison
Genetic deficiency of guanylyl cyclase A receptor vs Wild type mice (GC-A+/+)
Design
Preclinical
Follow-up
Evaluated at 4 months and 12 months of age
Authors
Loading...
GC-A deficiency induces hypertrophy and dysfunction in mice; leaves open whether GC-A modulation affects human HF progression.
Does permanent inhibition of guanylyl cyclase A receptor (GC-A) affect cardiac function and hypertrophy in mice?
Chronic hypertension resulting from GC-A deficiency in mice leads to progressive cardiac hypertrophy, interstitial fibrosis, and impaired contractility over time.
Michaela Kühn (2002) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: